BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4626316)

  • 21. The metabolic effects of glycerol administered to diabetic patients.
    Freund G
    Arch Intern Med; 1968 Feb; 121(2):123-9. PubMed ID: 4965864
    [No Abstract]   [Full Text] [Related]  

  • 22. Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences.
    Newton CA; Raskin P
    Arch Intern Med; 2004 Sep; 164(17):1925-31. PubMed ID: 15451769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes.
    Ravikumar B; Carey PE; Snaar JE; Deelchand DK; Cook DB; Neely RD; English PT; Firbank MJ; Morris PG; Taylor R
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E789-97. PubMed ID: 15572652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneity of insulin receptors in patients with untreated insulin-dependent diabetes mellitus.
    Pedersen O; Beck-Nielsen H; Sørensen NS; Svejgaard A
    J Clin Endocrinol Metab; 1982 Jul; 55(1):30-9. PubMed ID: 6804484
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diabetic acido-ketosis].
    Boukhris R; Ben Slama C; Mebazaa A
    Tunis Med; 1982; 60(4):128-33. PubMed ID: 6821452
    [No Abstract]   [Full Text] [Related]  

  • 26. The family practitioner and the juvenile diabetic.
    Kaye R
    Semin Drug Treat; 1974; 3(4):357-63. PubMed ID: 4207076
    [No Abstract]   [Full Text] [Related]  

  • 27. [Dynamic study of glycemia, insulinemia and free fatty acids in children genetically exposed to diabetes mellitus].
    Debry G; Manciaux M; Manciaux G; Laurent J; Cherrier P; Guisard D
    Diabete; 1968; 16(4):275-80. PubMed ID: 5730353
    [No Abstract]   [Full Text] [Related]  

  • 28. Hormonal counterregulation during severe hypoglycaemia under everyday conditions in patients with type 1 and insulin-treated type 2 diabetes mellitus.
    Holstein A; Hammer C; Plaschke A; Ptak M; Kuhn J; Diekmann J; Kleesiek K; Egberts EH
    Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):429-34. PubMed ID: 15372362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of magnesium in glucose homeostasis: therapeutic implications].
    Corica F; Allegra A; Giacobbe MS; Ceruso D
    Clin Ter; 1993 Jul; 143(1):45-55. PubMed ID: 8243023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remission phase in newly diagnosed insulin treated juvenile diabetes: behaviour of glucose, FFA, HGH and total-IRI during combined glucose arginine infusion; development of antibodies against exogenous insulin.
    Menzel R; Michaelis D; Neumann I; Schultz B; Wilke W; Wulfert P; Michael R; Bibergeil H
    Endokrinologie; 1973 Aug; 62(1):100-6. PubMed ID: 4785266
    [No Abstract]   [Full Text] [Related]  

  • 31. Fat metabolism in juvenile diabetes mellitus.
    Barta L; Szamosfalvi I; Tichy MV
    Acta Paediatr Acad Sci Hung; 1973; 14(2):81-4. PubMed ID: 4763563
    [No Abstract]   [Full Text] [Related]  

  • 32. Differences in metabolic and hormonal milieu in diabetic- and alcohol-induced ketoacidosis.
    Umpierrez GE; DiGirolamo M; Tuvlin JA; Isaacs SD; Bhoola SM; Kokko JP
    J Crit Care; 2000 Jun; 15(2):52-9. PubMed ID: 10877365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antecedent hypoglycemia does not alter increased epinephrine-induced lipolysis in type 1 diabetes mellitus.
    Hoffman RP
    Metabolism; 2006 Mar; 55(3):371-80. PubMed ID: 16483882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans.
    Guy DA; Sandoval D; Richardson MA; Tate D; Flakoll PJ; Davis SN
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E178-86. PubMed ID: 15585598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [On the clinical use of biguanides].
    Haese E
    Arzneimittelforschung; 1969 Apr; 19(4):633-8. PubMed ID: 5819164
    [No Abstract]   [Full Text] [Related]  

  • 36. Beta adrenergic blockade and juvenile diabetes: acute studies and long-term therapeutic trial. Evidence for the role of catecholamines in mediating diabetic decompensation following emotional arousal.
    Baker L; Barcai A; Kaye R; Haque N
    J Pediatr; 1969 Jul; 75(1):19-29. PubMed ID: 4978148
    [No Abstract]   [Full Text] [Related]  

  • 37. [Role of the adrenergic system in juvenile diabetes mellitus].
    Szewczyk L; Zajaczkowska M; Kornas-Dubejko A
    Pediatr Pol; 1979 Jul; 54(7):681-5. PubMed ID: 119206
    [No Abstract]   [Full Text] [Related]  

  • 38. Insulin receptors on monocytes from patients with ketosis-prone diabetes mellitus.
    Pedersen O; Beck-Nielsen H; Heding L
    Diabetes; 1978 Nov; 27(11):1098-104. PubMed ID: 102554
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolic homeostasis in juvenile diabetes mellitus. I. Role of growth hormone.
    Baker L; Root AW; Haque N; Kaye R
    Metabolism; 1969 Feb; 18(2):110-4. PubMed ID: 5812400
    [No Abstract]   [Full Text] [Related]  

  • 40. Observations on lipolysis in ketosis-resistant, growth-onset diabetes.
    Hagroo AA; Verma NP; Datta P; Ajmani NK; Vaishnava H
    Diabetes; 1974 Apr; 23(4):268-75. PubMed ID: 4207364
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.